Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19
WESTMINSTER -- Reven Holdings, Inc. today announced the first patient has been dosed in the Phase I/II trial of RJX in high-risk COVID-19 patients ( ClinicalTrials.gov Identifier: NCT04708340; ... Read More
Thursday April 29, 2021
Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in patients as a... Read More
Wednesday April 28, 2021
Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced results of a pre-clinical study demonstrating Ampion inhibits an important pro-inflammatory pathway in the types of immune cells... Read More
Friday April 9, 2021
CU: Carbon dioxide levels reflect COVID-19 risk
BOULDER -- Tracking carbon dioxide levels indoors is an inexpensive and powerful way to monitor the risk of people getting COVID-19, according to new research from the Cooperative Institute for... Read More
Friday April 9, 2021
Ampio Pharmaceuticals details early positive results for inhaled Ampion in COVID-19 distress
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) revealed preliminary positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in... Read More
Wednesday March 17, 2021
Everside Health approved to administer COVID vaccine in 22 states, 10 more states pending
DENVER -- Everside Health (formerly Paladina Health, Activate Healthcare and Healthstat), announced it has been approved to administer the COVID-19 vaccine in 22 states. With pending approval in... Read More
Monday March 1, 2021
Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater
LOVELAND -- Hach , a leader in water analysis, and Canada-based LuminUltra , a leader in biological diagnostic testing, have partnered to offer the world's first rapid, on-site testing solution for... Read More
Friday February 26, 2021
CSU vaccine research advances to develop coronavirus vaccine for next pandemic
FORT COLLINS -- As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other... Read More
Wednesday February 24, 2021
IN Sponsors
Browse
Entrepreneurial by Nature
